VapoCoolShot, Inc.

VapoCoolShot develops cost-effective revenue-enhancing solutions for healthcare providers, allowing them to anesthetize intact skin instantly with our proprietary, safe, non-drug technologies. No one likes injections or medical procedures. 2 in 3 children and 1 in 4 adults have a clinical fear of needles. Fear prevents many patients from getting necessary care, complicating future treatments and reducing potential facility revenue. CoolJect® solves this problem for healthcare providers; our Targeted Mist™ technology reaches anesthetic temperatures quicker than any other topical anesthetic. CoolJect® TargetedMist™ provides a fast, effective, lower-cost topical anesthetic that utilizes significantly less product to achieve the same numbing effect as other vapocoolant sprays. CoolJect is the only vapocoolant spray with a patented syringe holder, providing healthcare workers with a single-handed experience: spray and inject with one device in the same hand. CoolJect® Targeted Mist™: Less Expensive, More Effective, Quickest Onset topical anesthetic for injections and procedures. *Read our IFU before using CoolJect TargetedMist https://coolject.com/ifu/

• Employees 5
• Founded 2020
• Total Funding $250000